Trial Details
COMPLETEDBasic Information
| Clinical ID | c104 |
|---|---|
| Identifier | NCT00408174 |
| Trial Title | Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease|Ulcerative Colitis |
| Interventions | DRUG: Balsalazide disodium |
Participant Information
| Sponsor | Bausch Health Americas, Inc. |
|---|---|
| City | Tempe |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-05-06 |
|---|---|
| Primary Completion Date | 2025-07-07 |
| Completion Date | 2025-11-07 |